BBIO Latest Headlines

Wells Fargo Keeps Their Buy Rating on BridgeBio Pharma (BBIO)

at www.tipranks.com (Wed, 7-Jan 6:38 AM)

BridgeBio Pharma: Emerging Rare Disease Leader With Robust Growth Outlook and Discounted Valuation Supporting Buy Rating

at www.tipranks.com (Tue, 6-Jan 4:35 AM)

Bank of America Securities Remains a Buy on BridgeBio Pharma (BBIO)

at www.tipranks.com (Mon, 5-Jan 7:56 AM)

BridgeBio’s Upcoming Achondroplasia Webinar Set to Highlight Advancements in Skeletal Dysplasia Research

Market Chameleon (Fri, 2-Jan 9:01 AM)

Encaleret Achieves 76% Success Rate in Phase 3 CALIBRATE Study—BridgeBio Eyes 2026 FDA Submission

Market Chameleon (Wed, 29-Oct 7:42 AM)

BridgeBio Set to Announce Pivotal Phase 3 Data and Earnings—All Eyes on BBP-418 in LGMD2I/R9 Study

Market Chameleon (Mon, 27-Oct 11:17 AM)

BridgeBio’s BBP-418 Achieves Key Milestones in Phase 3 Study for LGMD2I/R9—All Endpoints Met and Dramatic 82% CK Reduction Observed

Market Chameleon (Mon, 27-Oct 7:38 AM)